Structure of correlation between variables of the ecuadorian registry of vaccination of first and second doses, covid-19
DOI:
https://doi.org/10.47187/perf.v1i29.209Keywords:
COVID-19, Correspondence, vaccination, doses applied, age groups, EcuadorAbstract
The objective of the study is to determine the correlation structure between the variables of the Ecuadorian first and second dose vaccination registry COVID-19. The records issued by the Ministry of Public Health of Ecuador were used, which has a total of 4,368,997 individuals vaccinated between the first and second doses. A simple correspondence analysis was performed between the variables of vaccines, provinces and age groups. It was found that the variables are not independent and the distribution of the vaccines was done in a differential way according to sociodemographic factors such as age groups and provinces, due to COVID-19 incidence levels prioritizing vaccination in provinces with a high level of occurrence of the disease and also the age groups considered vulnerable that could become seriously ill from the virus.
Downloads
References
Aquino-Canchari CR, Quispe-Arrieta R del C, Huaman Castillon KM. COVID-19 y su relación con poblaciones vulnerables. Rev habanera cienc méd. 2020;19:1–18.
Ministerio de Sanidad del Gobierno de España. Actualización n°13. Neumonía por nuevo conavirus (2019-nCov) en Wuhan, provincia de Hubei, (China). Cent Coord Alertas y Emergencias Sanit [Internet]. 2020;1–6. Disponible en: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Actualizacion_12_2019-nCoV_China.pdf
OMS. CONSIDERACIONES DE LA ORGANIZACIÓN PANAMERICANA DE LA SALUD CON RESPECTO A LA PROPAGACIÓN DEL NUEVO CORONAVIRUS EMERGENTE. Organización Mundial de la Salud (OMS) [Internet]. 2020 [citado 5 abril 2022]; Disponibel en: https://www.paho.org/bol/dmdocuments/REVISADA%20Consideraciones%20de%20la%20OPS%20nCoV%20China_FINAL.pdf
OMS. Alocución de apertura del Director General de la OMS en la rueda de prensa sobre la COVID-19 celebrada el 11 de marzo de 2020. Organización Mundial de la Salud (OMS) [Internet]. 2020 [citado 7 abril 2022]. Disponible en: https://www.who.int/es/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
Santos Sánchez N, Salas-Coronado R. Origin, structural characteristics, prevention measures, diagnosis and potential drugs to prevent and COVID-19. Medwave. 2020;20:e8037.
Maguiña Vargas C, Gastelo Acosta R, Tequen Bernilla A, Maguiña Vargas C, Gastelo Acosta R, Tequen Bernilla A. El nuevo Coronavirus y la pandemia del Covid-19. Rev Medica Hered [Internet]. 2020 [citado 7 abril 2022];31(2):125–131. Disponible en: https://revistas.upch.edu.pe/index.php/RMH/article/view/3776
Ortiz-Núñez R. Análisis métrico de la producción científica sobre COVID-19 en SCOPUS. Revista Cubana de Informacion en Ciencias de la Salud [Internet]. 2020 [citado 9 abril 2022];31(3):1–20. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S2307-21132020000300002
Carvalho T, Krammer F, Iwasaki A. The first 12 months of COVID-19: a timeline of immunological insights. Nat Rev Immunol [Internet]. 2021 [citado 12 abril 2022];21(4):245–256. Disponible en: https://doi.org/10.1038/s41577-021-00522-1
Luzuriaga JP, Marsico F, Garcia E, González V, Kreplak N, González S, et al. Impacto de la aplicación de vacunas contra COVID-19 sobre la incidencia de nuevas infecciones por SARS-COV-2 en PS de la Provincia de Buenos Aires. Scielo [Internet]. 2021 [citado 12 abril 2022];1:1–13. Disponible en: https://preprints.scielo.org/index.php/scielo/preprint/view/2068/3406
Brodeur A, Gray D, Islam A, Bhuiyan S. A literature review of the economics of COVID-19. J Econ Surv [Internet]. 2021 [citado 15 abril 2022];35(4):1007–1044. Disponible en: https://doi.org/10.1111/joes.12423
Jaramillo-Fuertes JE, Montoya-Chacón SP. Políticas públicas de vacunación contra el COVID-19 en el Ecuador en el periodo enero-agosto 2021. CIENCIAMATRIA [Internet]. 2021 [citado 15 abril 2022];7(3):19–47. Disponible en: https://www.cienciamatriarevista.org.ve/index.php/cm/article/view/569
Gaus D. COVID-19. Práctica Fam Rural [Internet]. 2021 [citado 20 marzo 2022];6(1). Disponible en: https://practicafamiliarrural.org/index.php/pfr/article/view/196
Donadio G, Choudhary M, Lindemer E, Pawlowski C, Soundararajan V. Counties with lower insurance coverage and housing problems are associated with both slower vaccine rollout and higher covid-19 incidence. Vaccines [Internet]. 2021 [citado 8 abril 2022];9(9):973. Disponible en: https://doi.org/10.3390/vaccines9090973
Klinger D, Blass I, Rappoport N, Linial M. Significantly improved COVID-19 outcomes in countries with higher bcg vaccination coverage: A multivariable analysis. Vaccines [Internet]. 2020 [citado 8 abril 2022];8(3):378. Disponible en : https://doi.org/10.3390/vaccines8030378
Gaona-Pineda EB, Mundo-Rosas V, Méndez-Gómez-Humarán I, Gómez-Acosta LM, Ávila-Arcos MA, Cuevas-Nasu L, et al. Vulnerabilidad, conocimiento sobre medidas de mitigación y exposición ante COVID-19 en adultos de México: Resultados de la ENSARS-CoV-2. Salud Publica Mex [Internet]. 2020 [citado 14 noviembre 2022];00:1–20. Disponible en: https://doi.org/10.21149/11875
Lazarus J V, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med [Internet]. 2021 [citado 11 noviembre 2022];27(2):225–228. Disponible en: https://doi.org/10.1038/s41591-020-1124-9
Garcia-Beltran WF, Lam EC, Astudillo MG, Yang D, Miller TE, Feldman J, et al. COVID-19-neutralizing antibodies predict disease severity and survival. Cell [Internet]. 2021 [citado 11 noviembre 2022];184(2):476-488.e11. Disponible en: https://www.sciencedirect.com/science/article/pii/S0092867420316858
OMS. Enfermedad por coronavirus (COVID-19): Accesibilidad y asignación de las vacunas. Organización Mundial de la Salud (OMS) [Internet]. 2021 [citado 17 abril 2022]. Disponible en: https://www.who.int/es/news-room/q-a-detail/coronavirus-disease-(covid-19)-vaccine-access-and-allocation
Levin EG, Lustig Y, Cohen C, Fluss R, Indenbaum V, Amit S, et al. Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months. N Engl J Med [Internet]. 2021 [citado 12 noviembre 2022];385(24):e84. Disponible en: https://doi.org/10.1056/NEJMoa2114583
Gao Y, Ding M, Dong X, Zhang J, Kursat Azkur A, Azkur D, et al. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy [Internet]. 2021 [citado 12 noviembre 2022];76(2):428–455. Disponible en: https://doi.org/10.1111/all.14657
Legros V, Denolly S, Vogrig M, Boson B, Siret E, Rigaill J, et al. A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity. Cell Mol Immunol [Internet]. 2021 [citado 10 noviembre 2022];18(2):318–327. Disponible en: https://doi.org/10.1038/s41423-020-00588-2
Ministerio de Salud Pública. Plan Nacional de Vacunación e Inmunización contra el COVID-19. Plan Vacunarse [Internet]. Ecuador;2021. Disponible en: https://www.planvacunarse.ec/
Abedi V, Olulana O, Avula V, Chaudhary D, Khan A, Shahjouei S, et al. Racial, Economic, and Health Inequality and COVID-19 Infection in the United States. J Racial Ethn Heal Disparities [Internet]. 2021 [citado 11 noviembre 2022];8(3):732–742. Disponible en: https://doi.org/10.1007/s40615-020-00833-4
Bhadra A, Mukherjee A, Sarkar K. Impact of population density on Covid-19 infected and mortality rate in India. Model Earth Syst Environ [Internet]. 2021 [citado 12 noviembre 2022];7(1):623–629. Disponible en: https://doi.org/10.1007/s40808-020-00984-7
Gupta A, Bherwani H, Gautam S, Anjum S, Musugu K, Kumar N, et al. Air pollution aggravating COVID-19 lethality? Exploration in Asian cities using statistical models. Environ Dev Sustain [Internet]. 2021 [citado 13 noviembre 2022];23(4):6408–6417. Disponible en: https://doi.org/10.1007/s10668-020-00878-9
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
